Medical Device Network-Updates The latest content updates from the www.medicaldevice-network.com web site http://www.medicaldevice-network.com/ en-us http://www.medicaldevice-network.com/ Medical Device Network-Updates http://www.medicaldevice-network.com/content/images/logo_big.gif Merck and AmoyDx to jointly introduce liquid biopsy RAS biomarker test in China http://www.medicaldevice-network.com/news/newsmerck-and-amoydx-to-jointly-introduce-liquid-biopsy-ras-biomarker-test-in-china-4963196 http://www.medicaldevice-network.com/news/newsmerck-and-amoydx-to-jointly-introduce-liquid-biopsy-ras-biomarker-test-in-china-4963196 Merck has entered into an agreement with Amoy Diagnostics (AmoyDx) to develop and commercialise the new ADx-SuperARMS liquid biopsy RAS test for metastatic colorectal cancer (mCRC). Thu, 28 Jul 2016 23:00:00 GMT Deals this week: Enigma Biomedical Group, Arecor, Globus Medical http://www.medicaldevice-network.com/news/newsdeals-this-week-enigma-biomedical-group-arecor-globus-medical-4962532 http://www.medicaldevice-network.com/news/newsdeals-this-week-enigma-biomedical-group-arecor-globus-medical-4962532 Enigma Biomedical Group (EBG), a company based in Toronto, Canada, has announced research collaboration with Biogen and Merck for the qualification and validation of Tau, a novel imaging agent developed by Merck. Thu, 28 Jul 2016 23:00:00 GMT Boston Scientific acquires Cosman Medical http://www.medicaldevice-network.com/news/newsboston-scientific-acquires-cosman-medical-4962974 http://www.medicaldevice-network.com/news/newsboston-scientific-acquires-cosman-medical-4962974 Medical device firm Boston Scientific has acquired US-based medical device manufacturer Cosman Medical for an undisclosed amount. Thu, 28 Jul 2016 23:00:00 GMT M&As this week: Luye Pharma Group, Fujifilm Holdings Corporation, Steris http://www.medicaldevice-network.com/news/newsmas-this-week-luye-pharma-group-fujifilm-holdings-corporation-steris-4962565 http://www.medicaldevice-network.com/news/newsmas-this-week-luye-pharma-group-fujifilm-holdings-corporation-steris-4962565 Luye Pharma Group has announced its intention to acquire the transdermal drug delivery systems (TDS) business of Acino by purchasing the entire issued share capital of Acino AG and Acino Supply AG for a purchase price of €245m ($268.8m). Thu, 28 Jul 2016 23:00:00 GMT Voxdale: Medical Equipment http://www.medicaldevice-network.com/downloads/whitepapers/manufacturing-software/voxdale-medical-equipment/ http://www.medicaldevice-network.com/downloads/whitepapers/manufacturing-software/voxdale-medical-equipment/ Voxdale (Antwerp, 2005) is a design, engineering and research agency for mechanical and mechatronical development of medical devices, medical equipment and production lines. Thu, 28 Jul 2016 16:31:00 GMT Mercator recruits first patient in LIMBO-ATX trial http://www.medicaldevice-network.com/news/newsmercator-recruits-first-patient-in-limbo-atx-trial-4962274 http://www.medicaldevice-network.com/news/newsmercator-recruits-first-patient-in-limbo-atx-trial-4962274 US-based medical device company Mercator MedSystems has recruited the first patient in its LIMBO-ATX trial to test the efficacy of localised drug delivery by the company’s patented Bullfrog Micro-Infusion Device to treat first critical limb ischemia … Wed, 27 Jul 2016 23:00:00 GMT Instrumentation Laboratory gets FDA 510(k) clearance of HemosIL HIT-Ab(PF4-H) assay http://www.medicaldevice-network.com/news/newsinstrumentation-laboratory-gets-fda-510k-clearance-of-hemosil-hit-abpf4-h-assay-4961465 http://www.medicaldevice-network.com/news/newsinstrumentation-laboratory-gets-fda-510k-clearance-of-hemosil-hit-abpf4-h-assay-4961465 Instrumentation Laboratory (IL), a developer of in-vitro diagnostic instruments, has secured the US Food and Drug Administration (FDA) 510(k) clearance of its HemosIL HIT-Ab (PF4-H) assay to be used on ACL TOP Family Hemostasis Testing Systems. Wed, 27 Jul 2016 23:00:00 GMT LabCorp to acquire Sequenom for $371m http://www.medicaldevice-network.com/news/newslabcorp-to-acquire-sequenom-for-371m-4961812 http://www.medicaldevice-network.com/news/newslabcorp-to-acquire-sequenom-for-371m-4961812 US-based healthcare diagnostics company Laboratory Corporation of America (LabCorp) has entered into a definitive agreement to acquire US-based medical technology company Sequenom for a total enterprise value of about $371m. Wed, 27 Jul 2016 23:00:00 GMT Cendres+Métaux Company Video http://www.medicaldevice-network.com/contractors/eng_services/cendresmetaux/5052867297001.html http://www.medicaldevice-network.com/contractors/eng_services/cendresmetaux/5052867297001.html Wed, 27 Jul 2016 06:13:00 GMT ElectroCore’s nVNS therapy decreases chronic migraine attacks http://www.medicaldevice-network.com/news/newselectrocores-nvns-therapy-decreases-chronic-migraine-attacks-4961113 http://www.medicaldevice-network.com/news/newselectrocores-nvns-therapy-decreases-chronic-migraine-attacks-4961113 US-based ElectroCore has reported a positive outcome from the Event study conducted on non-invasive Gammacore vagus nerve stimulation (nVNS) therapy in treating patients with chronic migraine. Tue, 26 Jul 2016 23:00:00 GMT Syneron Candela secures FDA approval for PicoWay picosecond laser for coloured tattoo removal http://www.medicaldevice-network.com/news/newssyneron-candela-secures-fda-approval-for-picoway-picosecond-laser-for-coloured-tattoo-removal-4959915 http://www.medicaldevice-network.com/news/newssyneron-candela-secures-fda-approval-for-picoway-picosecond-laser-for-coloured-tattoo-removal-4959915 Israel-based aesthetic device company Syneron Candela has secured the US Food and Drug Administration (FDA) approval for its PicoWay picosecond laser for coloured tattoo removal. Tue, 26 Jul 2016 23:00:00 GMT BioLight reports positive feasibility clinical study results of CellDetect technology http://www.medicaldevice-network.com/news/newsbiolight-reports-positive-feasibility-clinical-study-results-of-celldetect-technology-4960768 http://www.medicaldevice-network.com/news/newsbiolight-reports-positive-feasibility-clinical-study-results-of-celldetect-technology-4960768 Israel-based BioLight Life Sciences has reported positive results from a feasibility clinical study of its CellDetect technology in detecting prostate cancer cells in urine samples. Tue, 26 Jul 2016 23:00:00 GMT Transgenomic introduces CLIA test to detect drug resistant mutation for NSCLC http://www.medicaldevice-network.com/news/newstransgenomic-introduces-clia-test-to-detect-drug-resistant-mutation-for-nsclc-4959621 http://www.medicaldevice-network.com/news/newstransgenomic-introduces-clia-test-to-detect-drug-resistant-mutation-for-nsclc-4959621 US-based biotechnology company Transgenomic (TBIO) has introduced its new CLIA assays to detect the presence of the EGFR C797S mutation to address non-small cell lung cancer (NSCLC). Mon, 25 Jul 2016 23:00:00 GMT Penumbra introduces stroke thrombectomy technology ACE 68 Reperfusion Catheter http://www.medicaldevice-network.com/news/newspenumbra-introduces-stroke-thrombectomy-technology-ace-68-reperfusion-catheter-4959413 http://www.medicaldevice-network.com/news/newspenumbra-introduces-stroke-thrombectomy-technology-ace-68-reperfusion-catheter-4959413 US-based medical device company Penumbra has commercially introduced its thrombectomy device, the ACE 68 Reperfusion Catheter in the US. Mon, 25 Jul 2016 23:00:00 GMT Bellerophon gets approval in Belgium to begin Phase II trial of INOpulse to treat PH-COPD http://www.medicaldevice-network.com/news/newsbellerophon-gets-approval-in-belgium-to-begin-phase-ii-trial-of-inopulse-to-treat-ph-copd-4959093 http://www.medicaldevice-network.com/news/newsbellerophon-gets-approval-in-belgium-to-begin-phase-ii-trial-of-inopulse-to-treat-ph-copd-4959093 US-based biotherapeutics company Bellerophon has secured the Belgium health authority’s approval to initiate the Phase II trial for INOpulse to treat pulmonary hypertension in chronic obstructive pulmonary disease (PH-COPD). Mon, 25 Jul 2016 23:00:00 GMT Relievant Medsystems gets FDA 510(k) clearance for INTRACEPT system to treat CLBP http://www.medicaldevice-network.com/news/newsrelievant-medsystems-gets-fda-510k-clearance-for-intracept-system-to-treat-clbp-4957631 http://www.medicaldevice-network.com/news/newsrelievant-medsystems-gets-fda-510k-clearance-for-intracept-system-to-treat-clbp-4957631 US-based medical device company Relievant Medsystems has secured the US Food and Drug Administration (FDA) 510(k) clearance for its INTRACEPT intraosseous nerve ablation system to treat chronic lower back pain (CLBP). Sun, 24 Jul 2016 23:00:00 GMT Cytox launches genetic biomarker assay for research use and Alzheimer’s disease risk assessment http://www.medicaldevice-network.com/news/newscytox-launches-genetic-biomarker-assay-for-research-use-for-alzheimers-disease-risk-assessment-4957804 http://www.medicaldevice-network.com/news/newscytox-launches-genetic-biomarker-assay-for-research-use-for-alzheimers-disease-risk-assessment-4957804 UK-based medical technology company Cytox has launched its genetic biomarker research assay variaTECT for research use and to assess Alzheimer’s disease (AD) risk. Sun, 24 Jul 2016 23:00:00 GMT Deals this week: Teva Pharmaceutical, Euroimmun AG, T2 Biosystems http://www.medicaldevice-network.com/news/newsdeals-this-week-teva-pharmaceutical-euroimmun-ag-t2-biosystems-4955837 http://www.medicaldevice-network.com/news/newsdeals-this-week-teva-pharmaceutical-euroimmun-ag-t2-biosystems-4955837 Teva Pharmaceutical Industries, through its financial arm Teva Pharmaceutical Finance Netherlands, has announced a public placement of 3.15% senior notes due 2026. Thu, 21 Jul 2016 23:00:00 GMT Viracor-IBT gets FDA emergency use authorisation of Zika Virus Real-time RT-PCR assay http://www.medicaldevice-network.com/news/newsviracor-ibt-gets-fda-emergency-use-authorisation-of-zika-virus-real-time-rt-pcr-assay-4956328 http://www.medicaldevice-network.com/news/newsviracor-ibt-gets-fda-emergency-use-authorisation-of-zika-virus-real-time-rt-pcr-assay-4956328 Eurofins Scientific’s subsidiary Viracor-IBT Laboratories (Viracor-IBT) has received emergency use authorisation (EUA) from the US Food and Drug Administration (FDA) for its Zika Virus Real-time RT-PCR assay. Thu, 21 Jul 2016 23:00:00 GMT Cydar secures FDA 510(k) clearance for 3D surgical guidance software http://www.medicaldevice-network.com/news/newscydar-secures-fda-510k-clearance-for-3d-surgical-guidance-software-4957169 http://www.medicaldevice-network.com/news/newscydar-secures-fda-510k-clearance-for-3d-surgical-guidance-software-4957169 UK-based Cydar Medical has secured the US Food and Drug Administration (FDA) 510(k) clearance for its EV surgical guidance software to be used for x-ray guided vascular surgery. Thu, 21 Jul 2016 23:00:00 GMT